Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

[Detection of circulating and bone marrow myeloma cells in patients with multiple myeloma and its clinical significance].

Authors: Jiang, Yuan-Qiang  Li, Jian-Yong  Wu, Yu-Jie  Yang, Hui  Shen, Yun-Feng  Chen, Li-Juan  Xu, Wei  Qian, Si-Xuan  Wu, Han-Xin  Lu, Hua  Shen, Rui-Lan 
Citation: Jiang YQ, etal., Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Oct;14(5):908-12.
Pubmed: (View Article at PubMed) PMID:17096887

This study was aimed to investigate the correlation between circulating myeloma cells (CMC) and bone marrow myeloma cells (MMC) in patients with multiple myeloma (MM) and its clinical significance. Four-color flow cytometry was used to detect the percentage of CMC and MMC in 55 patients with MM. Other prognosis-associated factors such as beta(2) microglobulin (beta(2)-MG), serum albumin (Alb), chromosomal abnormalities and renal function were simultaneously analyzed. The patients were divided into four groups: group A, in which CMC and MMC were simultaneously detected; group B, in which only MMC were detected; group C, in which only CMC were detected; group D, in which no myeloma cells were detected in peripheral blood or bone marrow. The results showed that the concentrations of beta(2)-MG and creatinine were significantly increased and Alb markedly decreased in group A as compared with other groups. Statistical differences existed in the above-mentioned factors between patients with myeloma cells detected and not detected. The percentages of CMC or MMC in newly diagnosed, refractory and relapsed patients were apparently higher than those in patients with partial and complete remission, respectively. CMC were strikingly correlated with MMC. It is concluded that the percentages of CMC and MMC not only imply tumor load in MM patients, but also predict the progression of MM, respectively for patients with MM, in those patients CMC and MMC were simultaneously detected.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 11035276
Created: 2016-02-15
Species: All species
Last Modified: 2016-12-30
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.